Sarah Mcdonald, MD | |
18th Medical Group, Unit 5142, Apo, AP 96368-5142 | |
(445) 630-4089 | |
Not Available |
Full Name | Sarah Mcdonald |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 18th Medical Group, Apo, Armed Forces Pacific |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003377599 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Sarah Mcdonald, MD 18th Medical Group, Unit 5142, Apo, AP 96368 Ph: () - | Sarah Mcdonald, MD 18th Medical Group, Unit 5142, Apo, AP 96368-5142 Ph: (445) 630-4089 |
News Archive
While estimates of the overall risk of a thrombotic (blood clot) event recurrence vary, reports on contributing factors are contradictory, according to background information in the article. Knowledge of the risk of a thrombotic event recurrence and its determinants is relevant for clinical policy regarding screening for thrombophilia (increased risk for blood clot), duration of anticoagulant treatment, and treatment strategies in circumstances of increased risk.
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer and Nycomed, a privately owned pharmaceutical company, today announced that results of four phase III trials have been published in the prestigious peer-reviewed medical journal The Lancet showing that roflumilast, a phosphodiesterase 4 (PDE4) inhibitor, improved lung function and reduced exacerbations in patients with moderate to severe COPD.
The Austrian Breast & Colorectal Cancer Study Group, Alliance Foundation Trials, the Breast International Group, PrECOG, LLC, the German Breast Group, and the NSABP Foundation today announced that the independent Data Monitoring Committee for the global Phase 3 early breast cancer PALbociclib CoLlaborative Adjuvant Study trial determined that the study is unlikely to show a statistically significant improvement in the primary endpoint of invasive disease-free survival following a preplanned interim analysis.
Fluidigm will provide the latest updates for its upcoming Stem Cell Culture Chip at the World Stem Cell Summit being held in Baltimore on September 21 – 23. This specialized integrated fluidic circuit will enable a variety of cell culture applications, including allowing stem cell researchers to simplify and automate protocols for turning differentiated cells into stem cells, and later fine tuning the reprogramming of those stem cells into targeted differentiated cells.
At the heart of most, if not all cancers, lie a handful of wayward stem cells that feed the ever growing tumor mass, but their scarcity make it difficult for scientists to study them. Now, times of plenty may lie ahead as a breast cancer cell line , established long ago , turned out to behave a lot like cancer stem cells.
› Verified 7 days ago
Beatriz Eugenia Meza-valencia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 121 General Hospital, Department Of Pediatrics, Apo, AP 96205 Phone: 011-822-79178072 Fax: 011-822-79173094 | |
Meghan Rosborough, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Unit 45011 Box Bg, Apo, AP 96343 Phone: 315-262-4175 | |
Maggie Yau, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Brian D. Allgood Amc, Unit 15245, Apo, AP 96271 Phone: 050-333-7141 | |
Matthew G. Kesler, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 374th Mdg, Yokota Air Base, Japan, Unit 5071 Bldg 4408, Apo, AP 96326 Phone: 315-225-4983 | |
Yejin Yoo, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 51st Medical Group, Unit 2060, Apo, AP 96278 Phone: 031-784-2552 | |
Shreena Reddy, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Unit 5071, Apo, AP 96328 Phone: 042-552-2510 | |
Spencer Eldon Hart, MD (MAY 15, 2020) Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 18th Medical Group, Unit 5142, Apo, AP 96368 Phone: 315-630-4817 |